CHIU et al., Nature Prostate Cancer and Prostatic Disease , July 2022

Key takeaways

  • First pilot study to investigate the efficacy of transperineal targeted microwave ablation (TMA) in treating localized prostate cancer (PCa). Cohort of 15 patients.

  • Strong results: for the primary outcome, 91.3% (21/23) ablated area had no cancer in 6-month biopsy.

  • This transperineal TMA guided by MRI-Ultrasound fusion guidance and organ-based tracking was shown to be effective, safe, and easily applicable in men with localized PCa.

chiu pk et al. tma for ca prostate pcan 2022
Download